Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4IDB4
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 1 |
GO:0005509 | calcium ion binding | 5 | 1 |
GO:0043167 | ion binding | 2 | 1 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 57 | 59 | PF00675 | 0.543 |
CLV_PCSK_KEX2_1 | 57 | 59 | PF00082 | 0.348 |
CLV_PCSK_SKI1_1 | 141 | 145 | PF00082 | 0.389 |
CLV_PCSK_SKI1_1 | 49 | 53 | PF00082 | 0.429 |
CLV_PCSK_SKI1_1 | 87 | 91 | PF00082 | 0.431 |
DOC_USP7_MATH_1 | 102 | 106 | PF00917 | 0.650 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.694 |
LIG_14-3-3_CanoR_1 | 134 | 138 | PF00244 | 0.485 |
LIG_14-3-3_CanoR_1 | 87 | 92 | PF00244 | 0.432 |
LIG_14-3-3_CanoR_1 | 95 | 101 | PF00244 | 0.418 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.678 |
LIG_BIR_III_4 | 130 | 134 | PF00653 | 0.537 |
LIG_BRCT_BRCA1_1 | 65 | 69 | PF00533 | 0.509 |
LIG_FHA_2 | 68 | 74 | PF00498 | 0.467 |
LIG_LIR_Gen_1 | 75 | 85 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 138 | 143 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 31 | 36 | PF02991 | 0.423 |
LIG_LIR_Nem_3 | 75 | 81 | PF02991 | 0.391 |
LIG_NRBOX | 143 | 149 | PF00104 | 0.536 |
LIG_SH2_STAT5 | 23 | 26 | PF00017 | 0.439 |
LIG_SH3_1 | 42 | 48 | PF00018 | 0.430 |
LIG_SH3_3 | 10 | 16 | PF00018 | 0.652 |
LIG_SH3_3 | 42 | 48 | PF00018 | 0.430 |
LIG_SUMO_SIM_par_1 | 79 | 84 | PF11976 | 0.391 |
LIG_TRAF2_1 | 119 | 122 | PF00917 | 0.535 |
MOD_CK1_1 | 106 | 112 | PF00069 | 0.702 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.662 |
MOD_CK1_1 | 67 | 73 | PF00069 | 0.549 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.500 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.688 |
MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.628 |
MOD_GlcNHglycan | 7 | 11 | PF01048 | 0.669 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.615 |
MOD_GSK3_1 | 143 | 150 | PF00069 | 0.513 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.476 |
MOD_N-GLC_2 | 96 | 98 | PF02516 | 0.405 |
MOD_NEK2_1 | 147 | 152 | PF00069 | 0.549 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.416 |
MOD_PKA_2 | 133 | 139 | PF00069 | 0.525 |
MOD_PKA_2 | 94 | 100 | PF00069 | 0.434 |
MOD_Plk_2-3 | 73 | 79 | PF00069 | 0.414 |
MOD_Plk_4 | 143 | 149 | PF00069 | 0.490 |
MOD_Plk_4 | 64 | 70 | PF00069 | 0.554 |
MOD_Plk_4 | 73 | 79 | PF00069 | 0.391 |
MOD_SUMO_rev_2 | 55 | 65 | PF00179 | 0.530 |
TRG_ER_diArg_1 | 56 | 58 | PF00400 | 0.367 |
TRG_ER_diLys_1 | 151 | 155 | PF00400 | 0.538 |
TRG_Pf-PMV_PEXEL_1 | 22 | 26 | PF00026 | 0.380 |
TRG_Pf-PMV_PEXEL_1 | 57 | 61 | PF00026 | 0.589 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HX85 | Leptomonas seymouri | 67% | 93% |
A0A0S4JG18 | Bodo saltans | 53% | 100% |
A0A1X0P8S8 | Trypanosomatidae | 50% | 97% |
A0A3Q8IKE9 | Leishmania donovani | 99% | 100% |
A0A422NI72 | Trypanosoma rangeli | 54% | 100% |
A4HP05 | Leishmania braziliensis | 83% | 100% |
D0A2Y1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9ASR5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 99% |
Q4Q1T1 | Leishmania major | 93% | 100% |
V5BJX8 | Trypanosoma cruzi | 56% | 100% |